Agilent | A - Selling And Administration Expenses


Agilent reported $475M in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
Abbott USD 4.27B 669M Sep/2026
Agilent USD 475M 10M Jun/2026
Align Technology USD 410.55M 52.12M Sep/2026
Bio Techne USD 67.42M 41.91M Jun/2026
Bio-Rad Laboratories USD 212M 400K Jun/2026
Bruker USD 226.5M 12.4M Sep/2026
Charles River Laboratories USD 140.59M 88.31M Sep/2026
Danaher USD 2.16B 87M Sep/2026
Dentsply International USD 363M 1000K Sep/2026
Edwards Lifesciences USD 560.9M 300K Sep/2026
Henry Schein USD 819M 12M Sep/2026
Illumina USD 281M 8M Sep/2026
Intuitive Surgical USD 1.08B 465.5M Sep/2026
IQVIA Holdings USD 569M 5M Sep/2026
Laboratory Of America USD 611.4M 34.2M Sep/2026
Mettler Toledo International USD 267.16M 3.82M Sep/2026
Myriad Genetics USD 122.3M 6.7M Dec/2025
OraSure Technologies USD 13.21M 3.29M Dec/2025
Quest Diagnostics USD 523M 6M Sep/2026
Quidel USD 182.7M 7M Sep/2026
Repligen USD 83.59M 6.97M Sep/2026
Revvity USD 275.33M 3.25M Sep/2026
Roche Holding CHF 6.37B 908M Jun/2026
Thermo Fisher Scientific USD 1.86B 46M Sep/2026
Waters USD 398M 7M Sep/2026
Zimmer Biomet Holdings USD 855M 56.6M Sep/2026